Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
filingDate |
2013-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2016-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-104780924-B |
titleOfInvention |
Interferon-induced immunomodulator compounds |
abstract |
The compound of formula (I) and salt thereof are the inducers of human interferon: Wherein R 1 It is positive C 3‑6 Alkyl;R 2 It is hydrogen or methyl;R 3 It is hydrogen or C 1‑6 Alkyl, and m is the integer of the value with 03.The compound of induction human interferon can be used for treating various disorders, such as treatment allergic disease and other inflammatory disease (such as allergic rhinitis and asthma), infectious disease and cancer, and is also used as vaccine adjuvant. |
priorityDate |
2012-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |